Key Developments For Urologix Inc

Urologix Inc (ULGX.O) (Consolidated Issue listed on NASDAQ Capital Market)
As of  3:59pm EST
0.99USD
Price Change
-0.01
Percent Change
-1.00%
 
Research Another Stock: Symbol Look-up

Urologix, Inc. Announces Appointment of Stryker Warren, Jr. As Chief Executive Officer
Tuesday, 24 Jun 2008 04:05pm EDT 

Urologix, Inc. announced that its Board of Directors appointed Stryker Warren, Jr. as its Chief Executive Officer and a director. Mr. Warren assumes the office from Mitchell Dann who has served as Interim Chief Executive Officer since February 2008. Mr. Dann continues to serve as Chairman and a director. 

 
Urologix, Inc. Announces Long-Term Clinical Results
Thursday, 22 May 2008 06:11pm EDT 

Urologix, Inc. announced the presentation of long-term clinical results from a multi-center trial with the Urologix Cooled ThermoCath (CTC) Microwave Catheter for treatment of benign prostatic hyperplasia (BPH). The results showed the efficacy of the CTC Microwave Catheter is durable for at least five years and the freedom from additional minimally invasive or surgical procedures is 90%. The data from the study showed clinically significant improvement from baseline of the three major BPH evaluation criteria: urinary flow rate, symptom improvement, and quality of life at the 5-year follow-up. 

 
Urologix, Inc. Launches New CTC Advance Catheter
Friday, 16 May 2008 02:00pm EDT 

Urologix, Inc. announced that it is launching its Cooled ThermoTherapy (CTT) treatment catheter, CTC Advance at the 2008 American Urological Association Annual Meeting in Orlando, Florida being held May 17-22, 2008. 

 
Urologix, Inc. Announces Appointment Of Principal Financial Officer
Wednesday, 16 Apr 2008 04:00pm EDT 

Urologix, Inc. announced that its Board of Directors has appointed Rebecca J. Weber as the Company's Controller and Director of Finance. Ms. Weber will serve as the Company's principal financial officer and principal accounting officer. Ms. Elissa J. Lindsoe ceased serving as the Company's Chief Financial Officer concurrently with Ms. Weber's appointment. Ms. Lindsoe resigned as the Company's Chief Financial Officer to focus on personal matters. 

 
Urologix, Inc. Announces Leadership Changes
Monday, 25 Feb 2008 04:05pm EST 

Urologix, Inc. announced that its Board of Directors appointed Mitchell Dann as Chairman of the Board and interim Chief Executive Officer. Concurrently, the Board of Directors has accepted the resignation of Fred B. Parks as Chief Executive Officer and Chairman effective immediately 

 
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.